Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$165.67 - $199.94 $18.9 Million - $22.8 Million
114,272 New
114,272 $19.3 Million
Q2 2023

Aug 11, 2023

SELL
$160.94 - $186.23 $8.81 Million - $10.2 Million
-54,729 Reduced 81.42%
12,493 $2.15 Million
Q1 2023

May 15, 2023

BUY
$145.48 - $175.02 $4.63 Million - $5.57 Million
31,847 Added 90.03%
67,222 $11.2 Million
Q4 2022

Feb 13, 2023

BUY
$131.14 - $157.47 $420,828 - $505,321
3,209 Added 9.98%
35,375 $5.19 Million
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $3.46 Million - $4.26 Million
23,352 Added 264.94%
32,166 $4.77 Million
Q2 2022

Aug 11, 2022

SELL
$155.97 - $200.09 $7.29 Million - $9.35 Million
-46,717 Reduced 84.13%
8,814 $1.52 Million
Q1 2022

May 13, 2022

BUY
$181.39 - $234.03 $10.1 Million - $13 Million
55,531 New
55,531 $10.5 Million
Q3 2019

Nov 08, 2019

SELL
$112.57 - $128.43 $834,593 - $952,180
-7,414 Closed
0 $0
Q2 2019

Aug 09, 2019

SELL
$97.98 - $114.28 $299,524 - $349,353
-3,057 Reduced 29.19%
7,414 $841,000
Q1 2019

May 13, 2019

BUY
$81.56 - $100.67 $470,519 - $580,765
5,769 Added 122.69%
10,471 $1.05 Million
Q4 2018

Feb 13, 2019

SELL
$79.28 - $95.27 $2.33 Million - $2.81 Million
-29,449 Reduced 86.23%
4,702 $402,000
Q3 2018

Nov 09, 2018

BUY
$83.5 - $93.23 $2.47 Million - $2.76 Million
29,619 Added 653.55%
34,151 $3.13 Million
Q2 2018

Aug 07, 2018

SELL
$79.9 - $89.2 $1.78 Million - $1.98 Million
-22,222 Reduced 83.06%
4,532 $386,000
Q1 2018

May 03, 2018

BUY
$71.51 - $84.69 $1.26 Million - $1.49 Million
17,645 Added 193.71%
26,754 $2.23 Million
Q4 2017

Feb 09, 2018

SELL
$63.24 - $72.8 $175,554 - $202,092
-2,776 Reduced 23.36%
9,109 $656,000
Q3 2017

Nov 09, 2017

BUY
$59.73 - $65.4 $709,891 - $777,279
11,885
11,885 $758,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.